The Russian part of the human proteome project:first results and prospects

   
Ponomarenko E.A.1 , Zgoda V.G.1, Kopylov A.T.1, Poverennaya E.V.1, Ilgisonis E.V.1, Lisitsa A.V.1, Archakov A.I.1

1. Institute of Biomedical Chemistry, Moscow, Russia
Section: Miscellaneous
DOI: 10.18097/PBMC20156102169      PubMed Id: 25978384
Year: 2015  Volume: 61  Issue: 2  Pages: 169-175
The article summarizes the achievements of the pilot phase (2010-2014) of the Russian part of the international project “Human Proteome” and identifies the directions for further work on the study of the human chromosome 18 proteome in the framework of the project main phase (2015-2022). The pilot phase of the project was focused on the detection of at least one protein for each chromosome 18 protein-coding gene in three types of the biological material. The application of mass spectrometric detection of proteins by the methods of multiple reactions monitoring (MRM) and gene-centric approach made it possible to detect 95% of master forms of proteins, for 60% of which the quantitative assessment of the protein content was obtained in at least one type of the biological material. The task of the main phase of the project is to measure the proteome size of healthy individuals, taking into account the modified protein forms, providing for both the bioinformatics prediction of the quantity of proteins types and the selective experimental measurement of single proteoforms. Since the ranges of protein concentrations corresponding to the normal physiological state have not been identified, the work of the main phase of the project is focused on the study of clinically healthy individuals. The absence of these data complicates significantly the interpretation of the patients’ blood proteomic profiles and prevents creating diagnostic tests. In the long term prospect, implementation of the project envisages development of a diagnostic test system based on multiple reactions monitoring (MRM) for quantitative measurement of the protein forms associated with some diseases. Development of such test systems will allow predicting the extent of risk of different diseases, diagnosing a disease at its early stage and monitoring the effectiveness of the treatment.
Download PDF:  
Keywords: proteome, proteomics, transcriptomics, mass-spectrometry
Citation:

Ponomarenko, E. A., Zgoda, V. G., Kopylov, A. T., Poverennaya, E. V., Ilgisonis, E. V., Lisitsa, A. V., Archakov, A. I. (2015). The Russian part of the human proteome project:first results and prospects. Biomeditsinskaya Khimiya, 61(2), 169-175.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)